Home/Filings/4/0001193125-26-021452
4//SEC Filing

Elder Scot Michael 4

Accession 0001193125-26-021452

CIK 0001630627other

Filed

Jan 22, 7:00 PM ET

Accepted

Jan 23, 9:30 PM ET

Size

6.6 KB

Accession

0001193125-26-021452

Research Summary

AI-generated summary of this filing

Updated

Treace Medical (TMCI) Chief Legal Officer Receives 262,500 RSUs

What Happened

  • Scot Michael Elder, Treace Medical's Chief Legal & Compensation Officer and Corporate Secretary, was granted 262,500 restricted stock units (RSUs) on 2026-01-22 (reported 2026-01-23). The grant is recorded at $0 per share (typical for RSU awards). On the same date, 9,451 shares were disposed (withheld) to cover tax liability related to equity compensation; that withholding is recorded at $0 value in the filing.

Key Details

  • Transactions: Grant/Award (code A) — 262,500 RSUs acquired; Tax withholding/payment (code F) — 9,451 shares disposed.
  • Transaction date: January 22, 2026; Form 4 filed January 23, 2026 (timely).
  • Price: $0.00 per share for both entries (RSUs are non-cash awards; withholding is a share-for-tax settlement).
  • Vesting: Footnote F2 states the 262,500 RSUs vest in equal annual installments over 4 years, with first vesting on Jan 22, 2027 and final on Jan 22, 2030, subject to continued service.
  • Footnotes F1 and F3 reference additional restricted stock units (378,970 and 641,470) noted in the filing.
  • No open-market purchase or sale of shares was reported (the disposition was tax withholding, not a market sale).

Context

  • RSUs are compensation awards that convert to shares only as they vest; this grant increases potential future share issuance rather than representing an immediate market purchase or sale. The 9,451-share disposition reflects tax withholding to satisfy tax obligations on the award, a routine administrative action. The filing appears timely (reported the day after the transactions).

Insider Transaction Report

Form 4
Period: 2026-01-22
Elder Scot Michael
Chief Legl & Comp Off, CorpSec
Transactions
  • Tax Payment

    Common Stock

    [F1]
    2026-01-229,451534,286 total
  • Award

    Common Stock

    [F2][F3]
    2026-01-22+262,500796,786 total
Footnotes (3)
  • [F1]Includes 378,970 restricted stock units.
  • [F2]Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, with the first installment vesting on January 22, 2027 and the last installment vesting on January 22, 2030; subject to Reporting Person's providing continued service to Issuer through each vesting date.
  • [F3]Includes 641,470 restricted stock units.
Signature
/s/ Lisa Taylor as Attorney-in-fact for Scot Elder|2026-01-23

Documents

1 file

Issuer

TREACE MEDICAL CONCEPTS, INC.

CIK 0001630627

Entity typeother

Related Parties

1
  • filerCIK 0001916619

Filing Metadata

Form type
4
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 9:30 PM ET
Size
6.6 KB